What the supplied label says
200 mg root powder per capsule. This comes from the supplied Supplement Facts label; check the actual bottle for updates.
Explore this review
What the supplied label saysHow to interpret this ingredientRead it in the full formulaA worked comparison that avoids a false dose claimSources used on this pageHow to interpret this ingredient
The supplied panel identifies ginger powder rather than a standardized concentrated extract. That distinction matters when comparing a research paper: the botanical name alone is not enough to establish that two preparations are equivalent.
NCCIH’s ginger overview discusses possible knee-osteoarthritis symptom benefits and research-quality concerns. It also notes potential gastrointestinal side effects. The overview does not test this 200 mg entry within Joint Genesis.
To evaluate a cited study, record the form, daily quantity, duration and participant group. A trial using a larger extract dose cannot simply be scaled down mathematically to predict the effect of this powder. Conversely, a different number alone is insufficient to prove the ingredient has no role.
Read it in the full formula
One ingredient cannot settle the assessment of a multi-ingredient product. Review all five label entries, the evidence standard and safety questions together. Ingredient identity, preparation, dose and the person taking it all matter.
A worked comparison that avoids a false dose claim
Imagine a paper states that participants took a standardized ginger extract, but a product label only says root powder. The paper’s extract may have specified active constituents that are not listed for the powder. Neither matching the plant name nor multiplying the powder weight establishes equivalence.
For this product, record “200 mg root powder per one-capsule serving” before opening a reference. Then add the study’s exact preparation in a separate column. Leave unspecified information blank rather than guessing a conversion ratio. This makes the uncertainty visible and prevents an invented “clinically matched” dose.
Also distinguish an outcome for knee symptoms from outcomes such as nausea or a laboratory inflammatory marker. A successful result for another use does not become a joint-benefit claim just because the same plant was involved.